Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Recent Advances in Magnetoliposome for Heart Drug Delivery Publisher Pubmed



Namdari M1 ; Cheraghi M1 ; Negahdari B2 ; Eatemadi A2, 3 ; Daraee H2, 3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Cardiology, Lorestan University of Medical Sciences, Khoramabad, Iran
  2. 2. Department of Medical Biotechnology, School of advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Medical Biotechnology, School of Medicine, Lorestan University of Medical Sciences, Khoramabad, Iran

Source: Artificial Cells# Nanomedicine and Biotechnology Published:2017


Abstract

Magnetic nanoparticles (NPs) also have been subject of interest to the therapeutic and imaging field because of their unique magnetic properties. Magnetoliposomes (MLs) are made up of a combination of liposomes and magnetic NPs, and they have been proven to be a potential biomaterial to fields like magnetic-targeted drug delivery, MRI, etc. The efficiency of a drug delivery system to the heart determines the treatment strategy for most of the heart diseases. In this review article, we summarize the recent development and updates in the application of MLs as a drug delivery system for heart/cardiac diseases. © 2017 Informa UK Limited, trading as Taylor & Francis Group.
Other Related Docs
9. Inner Ear Drug Delivery Using Liposomes, Cellular and Molecular Biology (2017)
14. Novel Drug Delivery Strategies for Improving Econazole Antifungal Action, International Journal of Pharmaceutics (2015)
16. Stem Cell Therapies for Congenital Heart Disease, Biomedicine and Pharmacotherapy (2016)
17. Magnetic Nanogel Polymer of Bupivacaine for Ankle Block in Rats, Journal of Microencapsulation (2016)
18. Bioavailability, Biodistribution, and Toxicity of Fluorescent Metal Nanoclusters, Luminescent Metal Nanoclusters: Synthesis# Characterization# and Applications (2022)